
Shire makes two senior appointments
pharmafile | June 6, 2012 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Colpman, Judge, Shire
Shire has announced the promotion of David Colpman and Ann Judge (pictured) as two senior leaders within the firm.
Colpman, senior vice president, will assume responsibility for leading Shire’s global Business Development team and takes over from Barbara Deptula, executive vice president and chief corporate development officer, who retires in June.
Colpman has over 12 years of experience with Shire. Before joining the firm he worked at Glaxo Wellcome, Novo Nordisk and Boots Pharmaceuticals in a variety of business development and commercial roles. Colpman is a member of the Royal Pharmaceutical Society and began his industry career at ICI (now AstraZeneca) in formulation and manufacturing. He will report to Shire chief executive, Angus Russell.
Ann Judge, senior vice president of Shire’s global Human Resources (HR) team has joined the Shire Leadership Team. Judge has over 20 years of global HR experience in the pharmaceutical, chemical, and oil and gas industries, having begun her career with Dow Chemical.
She lived and worked in Germany in the late1990s and relocated to Switzerland in early 2000s, where she also supported the commercial Asia Pacific Region. Judge joined to lead the global HR team at Shire in late 2010, after six years with Wyeth Pharmaceuticals.
Related Content

Takeda plans to vacate all 1,000 staff from US HQ by the year’s end
Takeda has announced its plans to vacate all staff from its US headquarters in Deerfield, …

Novartis buys dry eye treatment Xiidra in deal worth $5.3 billion
Japanese multinational Takeda Pharmaceutical has agreed to sell its dry eye drug Xiidra to Swiss …

Top Ten most popular articles on Pharmafile.com this week!
With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger …






